SAGE

Sage Therapeutics
SAGE

Overview Fund Activity
Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

176 hedge funds and large institutions have $278M invested in Sage Therapeutics in 2024 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 52 increasing their positions, 58 reducing their positions, and 24 closing their positions.

Holders
176
Holders Change
+1
Holders Change %
+0.57%
% of All Funds
2.34%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
25
Increased
52
Reduced
58
Closed
24
Calls
$2.74M
Puts
$1.1M
Net Calls
+$1.64M
Net Calls Change
-$754K

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$24.9M
2
CP
2
Caligan Partners
New York
$16.6M
3
BFM
3
Boothbay Fund Management
New York
$7.54M
4
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$8.6M
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$6M

Top Sellers

1
RI
1
RTW Investments
New York
$16.3M
2
State Street
2
State Street
Massachusetts
$6.91M
3
PAI
3
Palo Alto Investors
California
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$22.4M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$26.3M
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
201
Simplex Trading
Illinois
– – – –
Wolverine Trading
202
Wolverine Trading
Illinois
– – – –
Group One Trading
203
Group One Trading
Illinois
– – – –
C
204
Covestor
United Kingdom
$0 7 +1 +17%
5 6 7 8
9